Case Report
Copyright ©The Author(s) 2022.
World J Clin Cases. Feb 6, 2022; 10(4): 1296-1310
Published online Feb 6, 2022. doi: 10.12998/wjcc.v10.i4.1296
Table 4 Review of previous studies reporting coronavirus disease 2019 and acute cholecystitis treatment approach
Ref.
Study design
Country
Sample size, n (%)
Age/sex (F:M)
COVID-19 diagnosis
Tokyo class
Treatment
Morbidity/PO complications
ICU, n (%)
LOS (d)
Mortality
Findings/histopathology
Çakır and Kabuli[8], 2021Retrospective studyTurkey18M: 14 (78%); F: 4 (22%); Age: 73.3 (67-81)RT-PCRGI: 3 (16.7%); GII: 9 (50%); GIII: 6 (33.3%)THGDNo complications3 (16.6%)16 (3-32)3 (16.6%)NR
Barabino et al[9], 2021Retrospective studyItaly 37: 36 non-COVID; 1 COVID64 (38-94); Male: 21 (56.7%); Female 16 (43.3%)RT-PCRGI: 13 (35.1%); GII: 15 (40.5%); GIII: 8 (21.6%); COVID: GII Antibiotic only 11 (29.7%); THGD 8 (21.6%); L 18 (48.7%); COVID: THGD 1Emergency LC 1; Bleeding 1; Cholangitis 229 (2-12)--
Martínez Caballero et al[10], 2021 Multicentre-combined (retrospective–prospective) cohort studySpain42 Age: COVID: 83 (65-87); COVID: 28 M/14 F Clinics 10.9%; Imaging test 11.3%; RT-PCR 12.5% GI: 112 (43.6%); GII: 121 (47.1%); GIII: 24 (9.3%) Antibiotic therapy 47.9%; Surgical treatment 31.5%; THGD 20.6%. COVID: 93.3% non surgical treatmentGallblader perforation 8.4%; Biliar setic shock 8.4%23%Non-COVID: 5 d (3–8). COVID: 11.0 d (7.5–27.5)Non-COVID: 3.25%; COVID: 11.9%-
Çiyiltepe et al[11], 2021Retrospective studyTurkey65 non-COVID; 7 COVIDAge: 57.3; F: 40 (55.6)/M: 32 (44.4) GI: 35 (48.6%); GII: 37 (51.3%)11 THGD--9.2 (6-20)--
Somuncu et al[12], 2021Retrospective studyTurkey4 COVID; 32 non-COVIDAge: 53 (26-78); M: 17/F: 19Thorax CT-Antibiotic therapy 14; THGD 14 (39%); LC 8 --7 (2-20)1: Cardiac arrest -
Puig et al[13], 2021Case reportSpain2M: 65/57 RT-PCRGIII: 2Percutaneous cholecystostomy 2Pulmonary tromboemboly 22340-
Abaleka et al[14], 2021Case reportUnited States1Age: 76; F RT-PCRGrade IIAntibiotics-----
Lovece et al[15], 2020Case reportItaly1Age: 42/MRT-PCRGrade IIILCGallblader perforation----
Famularo and Spada[16], 2021Letter/case reportItaly190/MRT-PCR +NRTHGDNoNo26NoNR
Vaishnav and Patel[17], 2021Observational/prospectiveIndia1650/F: 7 (29%); M: 17 (70%)RT-PCR + CT +GIIILCNoNR4.9NRNR
Alhassan et al[18], 2020Case reportQatar140/FConfirmed 14 d priorAACAntibioticsNoYes (1, 100%)NRNo-
Asti et al[19], 2020Letter/case reportItaly340-86/F: 1 (33%); M: 2 (66%)ConfirmedAACLCNRNRNRNRAcalculous, gangrene
Balaphas et al[20], 2020Letter/case reportSwitzerland283-84/F: 1 (50%); M: 1 (50%)RT-PCR +AACLC/AntibioticsNRYes (1, 50%)NRYes (1, 50%)qRT-PCR revealed the presence of SARS-CoV-2 in the gallbladder wall
Bruni et al[21], 2020Case reportItaly159/MRT-PCR +AC/GIIIOCNRYes (1, 100%)44NoGangrenous, Hemorrhagic, vasculitis
Cirillo et al[22], 2020Letter/case reportItaly179/MConfirmedAACCholecystectomyNoNRNRNoPerforated acalculous cholecystitis
Giulio et al[23], 2020Letter/case reportItaly145/FRT-PCR +AC/GILCNoNR30NoNR
Gupta et al[24], 2020Retrospective original articleIndia553.2/NRConfirmedACOCBile leakNR4-9NoAcute on chronic calculous cholecystitis, gangrenous acalculous cholecystitis
Kabir et al[25], 2020Letter/case reportSingapore1Middle-aged/MRT-PCR +Gangrenous cholecystitisSubtotal reconstituting OCNRNRNRNRNR
Lisotti et al[26], 2020Case reportItaly180/FCT suspiciousAC/GIIEUS-GBDNoNo1NRNR
Mattone et al[27], 2020Case reportItaly166/MRT-PCR +AACInitially THGDLCNoYesNRNoGangrenous gallbladder
F Narvaez et al[28], 2020Brief report/reviewUnited States1NR/FConfirmedACLCNoNoNRNoNear-gangrenous gallbladder
Safari et al[29], 2020Case reportIran175/FRT-PCR +CT +AC/GIILCNRYes (1, 100%)9YesNR
Ying et al[30], 2020Case reportChina 168/FRT-PCR +AC/GIITHGDNoNo25NoNR